Business News • PR NewsWire • Genetic Substudy Shows Fewer Major Cardiovascular Events With Ticagrelor (BRILINTA) Regardless of Relevant Genetic Variability in ACS Patients

Genetic Substudy Shows Fewer Major Cardiovascular Events With Ticagrelor (BRILINTA) Regardless of Relevant Genetic Variability in ACS Patients

Genetic Substudy Shows Fewer Major Cardiovascular Events With Ticagrelor (BRILINTA) Regardless of Relevant Genetic Variability in ACS Patients

WILMINGTON, Del., Aug. 29 /PRNewswire-FirstCall/ -- A new genetic substudy of PLATO (A Study of PLATelet Inhibition and Patient Outcomes) showed that the effects on a combined primary endpoint of cardiovascular death, myocardial infarction, or stroke seen in Acute Coronary Syndromes (ACS) patients w

View More : http://www.prnewswire.com/news-releases/genetic-substudy-shows-fewer-major-cardiovascular-events-with-ticagrelor-brilint...

Releted News by prnewswire

U.S. Census Bureau Daily Feature for August 29

Renegade Creation, Dan Hicks and Wayne Wallace in Concert in Fort Bragg, CA

Study Points to Key Genetic Driver of Severe Allergic Asthma

Rentrak Announces Official Box Office Totals for Weekend of August 27, 2010